Genotype-dependent activation or repression of HBV enhancer II by transcription factor COUP-TF1

被引:15
作者
Fischer, Silke F.
Schmidt, Katja
Fiedler, Nicola
Glebe, Dieter
Schuettler, Christian
Sun, Jianguang
Gerlich, Wolfram H.
Repp, Reinald
Schaefer, Stephan
机构
[1] Univ Rostock, Inst Med Mikrobiol Virol & Hyg, Abt Virol, D-18057 Rostock, Germany
[2] Univ Giessen, Inst Med Virol, D-35390 Giessen, Germany
[3] Univ Giessen, Zentrum Kinderheilkunde, D-35390 Giessen, Germany
[4] Klinikum Fulda, Klin Kinder & Jugendmed, Fulda, Germany
[5] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-8000 Munich, Germany
关键词
hepatitis B virus; hepatitis B virus x protein; COUP-TF1; genotype; enhancer II;
D O I
10.3748/wjg.v12.i37.6054
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To study the expression of HBV enhancer H by transcription factor COUP-TF1. METHODS: In order to study the regulation of HBV variants in the vicinity of the NRRE we cloned luciferase constructs containing the HBV enhancer II from variants and from HBV genotypes A and D and cotransfected them together with expression vectors for COUP-TF1 into HepG2 cells. RESULTS: Our findings show that enhancer 11 of HBV genotype A is also repressed by COUP-TF1. In contrast, two different enhancer 11 constructs of HBV genotype D were activated by COUP-TF1. The activation was independent of the NRRE because a natural variant wit a deletion of nt 1763-1770 was still activated by COUP-TFI. CONCLUSION: Regulation of transcription of the HBV genome seems to differ among HBV genomes derived from different genotypes. These differences in transcriptional control among HBV genotypes may be the molecular basis for differences in the clinical course among HBV genotypes. (C) 2006 The WJG Press. All rights reserved.
引用
收藏
页码:6054 / 6058
页数:5
相关论文
共 36 条
[1]   CONTROLLED SYNTHESIS OF HBSAG IN A DIFFERENTIATED HUMAN-LIVER CARCINOMA-DERIVED CELL-LINE [J].
ADEN, DP ;
FOGEL, A ;
PLOTKIN, S ;
DAMJANOV, I ;
KNOWLES, BB .
NATURE, 1979, 282 (5739) :615-616
[2]  
Ausubel FA, 1998, CURRENT PROTOCOLS MO
[3]   Hepatitis B virus genotypes: comparison of genotyping methods [J].
Bartholomeusz, A ;
Schaefer, S .
REVIEWS IN MEDICAL VIROLOGY, 2004, 14 (01) :3-16
[4]  
BERTRAM U, 1990, DEUT MED WOCHENSCHR, V115, P1253
[5]   Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication [J].
Buckwold, VE ;
Xu, ZC ;
Chen, M ;
Yen, TSB ;
Ou, JH .
JOURNAL OF VIROLOGY, 1996, 70 (09) :5845-5851
[6]  
CALDWELL CA, 1995, J CLIN GASTROENTEROL, V21, P10
[7]   Molecular variants of hepatitis B virus [J].
Carman, WF .
CLINICS IN LABORATORY MEDICINE, 1996, 16 (02) :407-&
[8]   Clinical significance of hepatitis B virus genotypes [J].
Chu, CJ ;
Lok, ASF .
HEPATOLOGY, 2002, 35 (05) :1274-1276
[9]  
DENECKE B, 1993, J BIOL CHEM, V268, P18076
[10]   Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis [J].
Elmore, LW ;
Hancock, AR ;
Chang, SF ;
Wang, XW ;
Chang, S ;
Callahan, CP ;
Geller, DA ;
Will, H ;
Harris, CC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (26) :14707-14712